Prospective Monitoring of in Vivo Biological Effects of Natalizumab (Avla-4, Tysabri®) in Patients with Ms
Autor: | Bar-Or, Amit, Niino, Masaaki, Simard, Marie-Lune, Bodner, Caroline, Alatab, Sudabeh, Fournier, Alyson, Gano, Dawn, Jin Kim, Ho |
---|---|
Zdroj: | In Clinical Immunology 2006 119 Supplement:S48-S48 |
Databáze: | ScienceDirect |
Externí odkaz: |